Market LIVE
Published markets; coverage varies by country
Product profile · United States

ARGATROBAN

 ·  Patent Litigation & Settlement History ↓

IngredientARGATROBAN
Application typeNDA
Application201811
Product001
Dosage formINJECTABLE
RouteINJECTION
Strength250MG/2.5ML (100MG/ML)
Approval date2015-03-23
Marketing statusDiscontinued
Status event—
ApplicantFRESENIUS KABI USA
Product source

Current GenericRadar decision

Year—
SelectionDISCONTINUED
ReviewFINAL
Anchor typeDISCONTINUATION
Anchor date—
Patent anchor—
Exclusivity anchor—
Protection date—
First Final ANDA—
Status event—

Discontinued in the original 2026-10-10 source. Actual marketing-discontinuation date is unverified. Evidence limits: actual discontinuation date unavailable; do not substitute the observation date or approval year.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
No patent facts are recorded for this product.

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · CURRENT_SNAPSHOT_NO_RECORD · Historical coverage: NOT_COMPLETE

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
091665 / 001FINAL_APPROVAL · FINAL_APPROVED2014-06-30—PH HEALTH LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
202626 / 001FINAL_APPROVAL · FINAL_APPROVED2014-06-30—MYLAN INSTITUTIONAL LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
204120 / 001FINAL_APPROVAL · FINAL_APPROVED2016-09-21—HOSPIRA INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
206698 / 001FINAL_APPROVAL · FINAL_APPROVED2018-01-26—AMNEAL PHARMACEUTICALS CO GMBHNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 4 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
091665 / 001PH HEALTH LTDFINAL_APPROVAL · FINAL_APPROVED2014-06-30 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
202626 / 001MYLAN INSTITUTIONAL LLCFINAL_APPROVAL · FINAL_APPROVED2014-06-30 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
204120 / 001HOSPIRA INCFINAL_APPROVAL · FINAL_APPROVED2016-09-21 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
206698 / 001AMNEAL PHARMACEUTICALS CO GMBHFINAL_APPROVAL · FINAL_APPROVED2018-01-26 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.